Dataset Open Access
Gündel, Daniel;
Teodoro, Rodrigo;
Ludwig, Friedrich-Alexander;
Heerklotz, Anne;
Toussaint, Magali;
Deuther-Conrad, Winnie;
Bormans, Guy;
Brust, Peter;
Kopka, Klaus;
Moldovan, Rares-Petru
{
"conceptrecid": "3148",
"owners": [
471
],
"conceptdoi": "10.14278/rodare.3148",
"updated": "2025-02-11T15:16:28.266681+00:00",
"links": {
"badge": "https://rodare.hzdr.de/badge/doi/10.14278/rodare.3149.svg",
"doi": "https://doi.org/10.14278/rodare.3149",
"conceptbadge": "https://rodare.hzdr.de/badge/doi/10.14278/rodare.3148.svg",
"conceptdoi": "https://doi.org/10.14278/rodare.3148",
"bucket": "https://rodare.hzdr.de/api/files/28e31c73-6bd4-4b8a-9bf3-08c3a2a18e73",
"html": "https://rodare.hzdr.de/record/3149",
"latest": "https://rodare.hzdr.de/api/records/3149",
"latest_html": "https://rodare.hzdr.de/record/3149"
},
"revision": 4,
"id": 3149,
"doi": "10.14278/rodare.3149",
"created": "2024-09-18T07:22:24.804167+00:00",
"metadata": {
"license": {
"id": "CC-BY-4.0"
},
"doi": "10.14278/rodare.3149",
"creators": [
{
"name": "G\u00fcndel, Daniel",
"orcid": "0000-0001-9743-2325"
},
{
"name": "Teodoro, Rodrigo"
},
{
"name": "Ludwig, Friedrich-Alexander",
"orcid": "0000-0002-4358-5171"
},
{
"name": "Heerklotz, Anne"
},
{
"name": "Toussaint, Magali",
"orcid": "0000-0002-1136-3857"
},
{
"name": "Deuther-Conrad, Winnie",
"orcid": "0000-0003-3168-3062"
},
{
"name": "Bormans, Guy"
},
{
"name": "Brust, Peter",
"orcid": "0000-0001-5555-7058"
},
{
"name": "Kopka, Klaus",
"orcid": "0000-0003-4846-1271"
},
{
"name": "Moldovan, Rares-Petru",
"orcid": "0000-0003-3119-7945"
}
],
"publication_date": "2024-09-18",
"relations": {
"version": [
{
"count": 1,
"is_last": true,
"index": 0,
"parent": {
"pid_type": "recid",
"pid_value": "3148"
},
"last_child": {
"pid_type": "recid",
"pid_value": "3149"
}
}
]
},
"description": "<p>What is already known \u2022 Increased expression of the CB2R in the brain is linked to certain neuropathological diseases. \u2022 First clinical trials for CB2R-directed therapies are conducted. What this study adds \u2022 [18F]JHU94620-d8 provides the potential to quantify the CB2R receptor density in the brain by positron-emission-tomography. Clinical significance \u2022 Stratification of patients for CB2R-directed therapies and follow up of the treatment response is needed.</p>",
"related_identifiers": [
{
"identifier": "10.1186/s41181-024-00319-2",
"relation": "isReferencedBy",
"scheme": "doi"
},
{
"identifier": "https://www.hzdr.de/publications/Publ-39600",
"relation": "isIdenticalTo",
"scheme": "url"
},
{
"identifier": "https://www.hzdr.de/publications/Publ-39547",
"relation": "isReferencedBy",
"scheme": "url"
},
{
"identifier": "10.14278/rodare.3148",
"relation": "isVersionOf",
"scheme": "doi"
}
],
"doc_id": "1",
"access_right_category": "success",
"communities": [
{
"id": "rodare"
}
],
"access_right": "open",
"resource_type": {
"title": "Dataset",
"type": "dataset"
},
"pub_id": "39600",
"keywords": [],
"title": "Data publication: Development and Evaluation of Deuterated [18F]JHU94620 Isotopologues for the Non-invasive Assessment of the Cannabinoid type 2 Receptor in Brain"
},
"files": [
{
"key": "18FJHU94620_gammacounter_results15Jan2020.xlsx",
"size": 15436,
"checksum": "md5:55b39f77b300f1f1cbfdace12f5ea7cf",
"links": {
"self": "https://rodare.hzdr.de/api/files/28e31c73-6bd4-4b8a-9bf3-08c3a2a18e73/18FJHU94620_gammacounter_results15Jan2020.xlsx"
},
"bucket": "28e31c73-6bd4-4b8a-9bf3-08c3a2a18e73",
"type": "xlsx"
}
],
"stats": {
"volume": 540260.0,
"unique_downloads": 35.0,
"version_unique_downloads": 35.0,
"unique_views": 390.0,
"downloads": 35.0,
"version_unique_views": 390.0,
"version_views": 436.0,
"version_downloads": 35.0,
"version_volume": 540260.0,
"views": 436.0
}
}
| All versions | This version | |
|---|---|---|
| Views | 436 | 436 |
| Downloads | 35 | 35 |
| Data volume | 540.3 kB | 540.3 kB |
| Unique views | 390 | 390 |
| Unique downloads | 35 | 35 |